A practical approach to the diagnosis of systemic amyloidoses

Blood

Volumn 125, Issue 14, 2015, Pages 2239-2244

  De Larrea, Carlos Fernández ^a,b   Verga, Laura ^a   Morbini, Patrizia ^a   Klersy, Catherine ^c   Lavatelli, Francesca ^a   Foli, Andrea ^a   Obici, Laura ^a   Milani, Paolo ^a   Capello, Gian Luca ^a   Paulli, Marco ^a   Palladini, Giovanni ^a   Merlini, Giampaolo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; CONGO RED; AMYLOID;

ABDOMINAL FAT; ABDOMINAL FAT ASPIRATION BIOPSY; ADULT; AGED; AMYLOIDOSIS; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; LIGHT CHAIN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; CHEMISTRY; CLASSIFICATION; FINE NEEDLE ASPIRATION BIOPSY; METABOLISM; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ABDOMINAL FAT; ADULT; AGED; AGED, 80 AND OVER; AMYLOID; AMYLOIDOSIS; BIOPSY, FINE-NEEDLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84926645279     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-11-609883     Document Type: Article

References (38)

1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583-596.
2. Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol. 2011;29(14):1924-1933.
3. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta. 2005;1753(1):11-22.
4. Leung N, Nasr SH, Sethi S. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood. 2012;120(16):3206-3213.
5. Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21(4):221-224.
6. Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132(4):522-523.
7. Picken MM, Herrera GA. The burden of "sticky" amyloid: typing challenges. Arch Pathol Lab Med. 2007;131(6):850-851.
8. Solomon A, Murphy CL, Westermark P. Unreliability of immunohistochemistry for typing amyloid deposits. Arch Pathol Lab Med. 2008;132(1):14-15, author reply 14-15.
9. Satoskar AA, Burdge K, Cowden DJ, Nadasdy GM, Hebert LA, Nadasdy T. Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med. 2007;131(6):917-922.
10. Lachmann HJ, Booth DR, Booth SE, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002;346(23):1786-1791.
11. Schönland SO, Hegenbart U, Bochtler T, et al. Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood. 2012;119(2):488-493.
12. Lavatelli F, Perlman DH, Spencer B, et al. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics. 2008;7(8):1570-1583.
13. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR III, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114(24):4957-4959.
14. Brambilla F, Lavatelli F, Di Silvestre D, et al. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood. 2012;119(8):1844-1847.
15. Herrera GA, Paul R, Turbat-Herrera EA, et al. Ultrastructural immunolabeling in the diagnosis of light-chain-related renal disease. Pathol Immunopathol Res. 1986;5(2):170-187.
16. Arbustini E, Morbini P, Verga L, et al. Light and electron microscopy immunohistochemical characterization of amyloid deposits. Amyloid. 1997;4(3):157-170.
17. Verga L, Morbini P, Palladini G, et al. Amyloid typing: immunoelectron microscopy. In: Picken MM, Dogan A, Herrera GA, eds. Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations. New York, NY: Humana Press, Springer Science-Business Media; 2012:249-260.
18. Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid. 2002;9(2):108-114.
19. Obici L, Bellotti V, Mangione P, et al. The new apolipoprotein A-I variant leu (174)-. Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol. 1999;155(3):695-702.
20. Ferlini A, Obici L, Manzati E, et al. Mutation and transcription analysis of transthyretin gene in Italian families with hereditary amyloidosis: a putative novel hot spot' in codon 47. Clin Genet. 2000;57(4):284-290.
21. Puchter M, Sweat F, Levine M. On the binding of Congo Red by amyloid. J Histochem Cytochem. 1962;10:355-364.
22. Westermark GT, Johnson KH, Westermark P. Staining methods for identification of amyloid in tissue. Methods Enzymol. 1999;309:3-25.
23. Planté-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10(12):1086-1097.
24. Foli A, Palladini G, Caporali R, et al. The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients. Amyloid. 2011;18(Suppl 1):80-82.
25. Westermark P. Occurrence of amyloid deposits in the skin in secondary systemic amyloidosis. Acta Pathol Microbiol Scand [A]. 1972;80(6):718-720.
26. Stenkvist B, Westermark P, Wibell L. Simple method of diagnostic screening for amyloidosis. Ann Rheum Dis. 1974;33(1):75-76.
27. Soares SM, Fervenza FC, Lager DJ, Gertz MA, Cosio FG, Leung N. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis. 2008;52(6):1079-1083.
28. Brambilla F, Lavatelli F, Di Silvestre D, et al. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. J Proteome Res. 2013;12(12):5642-5655.
29. Lavatelli F, Valentini V, Palladini G, et al. Mass spectrometry-based proteomics as a diagnostic tool when immunoelectron microscopy fails in typing amyloid deposits. Amyloid. 2011;18(suppl 1):64-66.
30. Westermark P. Amyloid diagnosis, subcutaneous adipose tissue, immunohistochemistry and mass spectrometry. Amyloid. 2011;18(4):175-176.
31. Westermark P, Davey E, Lindbom K, Enqvist S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem. 2006;108(3):209-213.
32. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 2008;216(2):253-261.
33. Ikeda S, Sekijima Y, Tojo K, Koyama J. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid. 2011;18(4):211-215.
34. Rapezzi C, Quarta CC, Guidalotti PL, et al. Role of (99m) Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4(6):659-670.
35. Bokhari S, Castanõ A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m) Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6(2):195-201.
36. Comenzo RL, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood. 2006;107(9):3489-3491.
37. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood. 2001;97(9):2900-2902.
38. Palladini G, Russo P, Bosoni T, et al. Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. Clin Chem. 2009;55(3):499-504.